51�Թ���

OJ Watson, G Barnsley, J Toor, AB Hogan, P Winskill, AC Ghani. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. The Lancet Infectious Diseases, 23-06-2022. doi:

A Brizzi, C Whitaker, LMS Servo et al. Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals. Nature Medicine, 10 May 2022. doi:

E Lavezzo, M Pacenti, L Manuto et al. Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history. BMC Genome Medicine, 10 June 2022. doi:

L Sibissi, A von Gottberg, L Thukral et al. An early warning system for emerging SARS-CoV-2 variants. Nature Medicine, 30 May 2022. doi:

P Elliot, O Eales, N Steyn et al. Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England. Science, 24-05-2022. doi:

M Drolet, A Godbout, M Mondor et al. Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study. BMC Public Health, 23 May 2022. doi:

S Mandal, K Parchani, N Arinaminpathy, S Sarkar, B Bhargava, S Panda. ‘Imperfect but useful’: pandemic response in the Global South can benefit from greater use of mathematical modelling. BMJ Global Health, 11 May 2022. doi:

G Leech, C Rogers-Smith, J Teperowski Monrad et al. Mask wearing in community settings reduces SARS-CoV-2 transmission. PNAS, 31 May 2022. doi:

L Subissi, A von Gottberg, L Thukral et al. An early warning system for emerging SARS-CoV-2 variants. Nature Medicine, 30 May 2022. doi:

NF Brazeau, R Verity, S Jenks et al. Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling. Nature Communications Medicine, 19 May 2022. doi:

L Lenggenhager, R Martischang, J Sauser et al. Occupational and community risk of SARS-CoV-2 infection among employees of a long-term care facility: an observational study. BMC Antimicrobial Resistance & Infection Control, 18 March 2022. doi:

M Chadeau-Hyam, O Eales, B Bodinier et al. Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study. eClinicalMedicine, June 2022. doi:

H Xin, Y Li, P Wu et al. Estimating the Latent Period of Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases, 1 May 2022. doi:            

D. Haw, G Forchini, P Doohan et al. Optimizing social and economic activity while containing SARS-CoV-2 transmission using DAEDALUS. Nature Computational Science, 28-04-2022. doi:  

M Whitaker, J Elliott, M Chadeau-Hyam et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nature Communications, 12-04-2022. doi:

EY Cramer, EL Ray, VK Lopez et al. Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States. PNAS, 08-04-2022. doi:

M Pons-Salort, J John, OJ Watson et al. Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India. Emerging Infectious Diseases, 04-04-2022. doi:

B Killingley, AJ Mann, M Kalinova et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nature medicine, 31-03-2022. doi:

L Lenggenhager, R Martischang, J Sauser et al. Occupational and community risk of SARS-CoV-2 infection among employees of a long-term care facility: an observational study. BMC Antimicrobial Resistance & Infection Control, 18 March 2022. doi:

A Brizzi, M O’Driscoll, I Dorigatti. Refining reproduction number estimates to account for unobserved generations of infection in emerging epidemics. Clinical Infectious Diseases, 17 February 2022. doi:

T Nyberg, NM Ferguson, SG Nash et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. The Lancet, 16 March 2022. doi:

D Olivera Mesa, AB Hogan, OJ Watson GD Charles, K Hauck, A Ghani, P Winskill. Modelling the impact of vaccine hesitancy in prolonging the need for Non-Pharmaceutical Interventions to control the COVID-19 pandemic. Nature Communications, 10 February 2022. doi:

D Aggarwal, AJ Page, U Schaefer et al. Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission. Nature Communications, 23-02-2022. doi:

L Manuto, M Grazioli,A Spitaleri et al. Rapid SARS-CoV-2 Intra-Host and Within-Household Emergence of Novel Haplotypes. Viruses, 15-02-2022. doi:

HJT Unwin, S Hillis, L Cluver et al. Global, regional, and national minimum estimates of children affected by COVID-19-associated orphanhood and caregiver death, by age and family circumstance up to Oct 31, 2021: an updated modelling study. The Lancet Child & Adolescent Health, 24-02-2022. doi:

H Ward, M Whitaker, B Flower et al. Population antibody responses following COVID-19 vaccination in 212,102 individuals. Nature Communications (16-02-2022). doi:

LF Reyes, S Murthi E Garcia-Gallo et al. Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study. ERJ Open Research (14-02-2022). doi:

P Elliot, B Bodinier, O Eales et al. Rapid increase in Omicron infections in England during December 2021: REACT-1 study. Science (08-02-2022). doi:

M Ghafari, L du Plessis, J Raghwani et al. Purifying Selection Determines the Short-Term Time Dependency of Evolutionary Rates in SARS-CoV-2 and pH1N1 Influenza. Molecular Biology and Evolution, 17 January 2022. doi:

JD Challenger, CY Foo, Y Wu et al. Modelling upper respiratory viral load dynamics of SARS-CoV-2. BMC Medicine, 13 January 2022. doi:

CA Prete, LF Buss, R Buccheri et al.  Reinfection by the SARS-CoV-2 Gamma variant in blood donors in Manaus, Brazil. BMC Infectious Diseases, 05-02-2022. doi:

BB Lindsey, CJ Villabona-Arenas, F Campbell et al. Characterising within-hospitalSARS-CoV-2 transmission events using epidemiological and viral genomic data across two pandemic waves. Nature Communications, 3 February 2022. doi:

M Chadeau-Hyam, H Wang, O Eales et al. SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys. The Lancet Respiratory Medicine, 24-01-2022. doi:

T Mourier, M Shuaib, S Hala et al. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load. Nature Communications, 1 January 2022. doi:

P Mee, N Alexander, P Mayaud t al. Tracking the emergence of disparities in the subnational spread of COVID-19 in Brazil using an online application for real-time data visualisation: A longitudinal analysis. The Lancet Regional Health – Americas, January 2022. doi:

KV Parag, BJ Cowling, CA Donnelly. Deciphering early-warning signals of SARS-CoV-2 elimination and resurgence from limited data at multiple scales. Journal of the Royal Society, 15-12-2021. doi:

L Scott, NY Hsiao, S Moyo et al. Track Omicron’s spread with molecular data. Science, 9-12-2021. doi:

H Houston, S Hakki, TD Pillay et al. Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts. European Respiratory Journal 2021. doi:

VC Nicolete, PT Rodrigues, IC Johansen et al. Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated With Increased Coronavirus Disease 2019 (COVID-19) Risk in a Population-Based Cohort Study. Clinical Infectious Diseases, 01-12-2021. doi:

EA Kendall, N Arinaminpathy, JA Sacks et al. Antigen-based Rapid Diagnostic Testing or Alternatives for Diagnosis of Symptomatic COVID-19 – A Simulation-based Net Benefit Analysis. Epidemiology, 11-2021. doi:

ISARIC Clinical Characterisation Group, MD Hall, J Baruch et al. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: an observational cohort. eLife, 23-11-2021.doi:

P Elliot, D Haw, H Wang et al. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant. Science, 02-11-2021. doi:

R McCabe, MD Kont, N Schmit et al. Communicating uncertainty in epidemic models. Epidemics, 02-11-2021. Doi:

D Gurdasani, S Bhatt, A Costello et al. Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis. Journal of the Royal Society of Medicine, 01-11-2021. doi:

A Singanayagam, S Hakki, J Dunning et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. The Lancet, 28-10-2021. doi:

LR Williams NM Ferguson, CA Donnelly, NC Grassly. Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates. Clinical Infectious Diseases, 26-10-2021. Doi:  

R Sonabend, LK Whittles, N Imai et al. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study. The Lancet, 27-10-2021. doi:

LR Williams, NM Ferguson, CA Donnelly, NC Grassly. Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates. Clinical Infectious Diseases, 26-10-2021. doi:

WM de Souza, SP Muraro, GF Souza et al. Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines. Viruses, 22-10-2021. doi:

G Milne, T Hames, C Scotton et al. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?  The Lancet Respiratory Medicine, 21-10-2021. Doi:

HS Vohringer, T Sanderson, M Sinnott et al. Genomic reconstruction of the SARS-CoV-2 epidemic in England. Nature, 14-10-2021. doi:

MS Dhar, R Marwal, VS Radhakrishnan et al. Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India. Science, 14-10-2021. doi:

RM Anderson, C Vegvari, TD Hollingsworth et al. The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome. Interface Focus, 12-10-2021. Doi:

C Whittacker, PGT Walker, M Alhaffar et al. Under-reporting of deaths limits our understanding of true burden of COVID-19. The BMJ, 12-10-2021. Doi:

Y Mo, DW Eyre, SF Lumley et al. Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study. PLoS Medicine, 12-10-2021. doi:

R McCabe, CA Donnelly. Disease transmission and control modelling at the science–policy interface. Interface Focus, 12-10-2021. doi:

SD Hillis, A Blenkinsop, A Villaveces A et al. COVID-19-associated Orphanhood and Caregiver Death in the United States. Pediatrics 07-10-2021. doi:

J Ohrnberger, A Segal, G Forchini et al. The impact of a COVID-19 lockdown on work productivity under good and poor compliance. European Journal of Public Health, 05-10-2021. Doi:

M Sharma, S Mindermann, C Rogers-Smith et al. Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe. Nature, 05-10-2021. doi:  

B Davies, M Araghi, M Moshe et al. Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key Workers. Open Forum Infectious Diseases, 04-10-2021. doi:

WM Souza, MR Amorim, R Sesti-Costa et al. Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study. The Lancet Microbe, 01-10-2021. doi:

A Desai, P Nouvellet, S Bhatia, A Cori, B Lassmann. Data journalism and the COVID-19 pandemic: opportunities and challenges. Lancet Digital Health, 01-10-2021. doi:

J Elliott, M Whitaker, B Bodinier et al. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLOS Medicine, 28-09-2021. doi:

NA Molodecky, H Jafari, RM Safdar et al. Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic. Vaccine, 25-09-2021. doi:

MAC Vollmer, S Radhakrishnan, MD Kont et al. The impact of the COVID-19 pandemic on patterns of atendance at emergency departments in two large London hospitals: an observational study. BMC Health Services Research, 23-09-2021. Doi:

H Xin, Y Li, P Wu et al. Estimating the Latent Period of Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases, 22-09-2021. Doi:

C Whittaker, OJ Watson, C Alvarez-Moreno et al. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis. Clinical Infectious Diseases, 21-09-2021. doi:

A O’Toole, V Hill, OG Pybus et al. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch. Wellcome Open Research, 17-09-2021. doi:

S Mishra, JA Scott, DJ Laydon et al. Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling. Scientific Reports, 11-09-2021. doi:

P Mlcochova, SA Kemp, MS Dhar et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature, 06-09-2021. doi:  

S Mishra, S Mindermann, M Sharma et al. Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England. Lancet EClinicalMedicine, 01-09-2021. doi:  

H Wilde, T Mellan, I Hawryluk et al. The association between mechanical ventilator compatible bed occupancy and mortality risk in intensive care patients with COVID-19: a national retrospective cohort study. BMC Medicine, 30-08-2021. doi:  

MUG Kraemer, V Hill, C Ruis et al. Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence. Science, 19-08-2021. doi:

J. D’Aeth, S Ghosal, F Grimm, et al. Optimal national prioritization policies for hospital care during the SARS-CoV-2 pandemic. Nature Computational Science, 13-08-2021. Doi:

S Mishra, JA Scott, DJ Laydon et al. Comparing the responses of the UK, Sweden and Denmark to COVID-19 using counterfactual modelling. Nature Sci Rep, 11-08-2021. doi:  

T Mangal, C Whittaker, D Nkhoma et al. Potential impact of intervention strategies on COVID-19 transmission in Malawi: a mathematical modelling study. BMJ Open, 22-07-2021. doi:

S Hillis, HJT Unwin, Y Chen et al. Global minimum estimates for COVID-19-associated orphanhood and deaths among caregivers: a modelling study. Lancet, 20-07-2021. doi:

I Dorigatti, E Lavezzo, L Manuto et al. SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’. Nature Communications, 19-07-2021. doi:

E Knock, L Whittles, J Lees, et al. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England. Science Translational Medicine. 14-07-2021 DOI:

KAM Gaythorpe, S Bhatia, T Mangal et al. Children’s role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility. Nature Scientific Reports, 06-07-2021. Doi:

S Mandal, N Arinaminpathy, B Bhargava, S Panda. India’s pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis. BMJ Open, 02-07-2021. doi:

R Silhol, L Geidelberg, KM Mitchell et al. Assessing the Potential Impact of Disruptions Due to COVID-19 on HIV Among Key and Lower-Risk Populations in the Largest Cities of Cameroon and Benin. JAIDS, 01-07-2021. doi:

S Mandal, N Arinaminpathy, B Bhargava, S Panda. Responsive and agile vaccination strategies against COVID-19 in India. The Lancet Global Health, 01-07-2021. doi:

ISARIC Clinical Characterisation Group (including Donnelly CA). COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study. Infection, 25-06-2021. doi:

TP Smith, S Flaxman, AS Gallinat et al. Temperature and population density influence SARS-CoV-2 transmission in the absence of nonpharmaceutical interventions. PNAS, 22-06-2021. doi:

BA Djaafara, C Whittaker, OJ Watson et al. Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout. BMC Medicine, 18-06-2021. doi:

MS Kiti, OGAguolu, CY Liu et al. Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020. Epidemics, 17-06-2021. doi:

N Arinaminpathy, J Das, TH McCormick, P Mukhopadhyay, N Sircar. Quantifying heterogeneity in SARS-CoV-2 transmission during the lockdown in India. Epidemics, 17-06-2021. doi:

S Bhatia, N Imai, G Cuomo-Dannenburg et al. Estimating the number of undetected COVID-19 cases among travellers from mainland China. Wellcome Open Research, 15-06-2021. doi:

B Meng, SA Kemp, G Papa et al.  Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Reports, 08-06-2021. doi:

S Mandal, N Arinaminpathy, B Bhargava, S Panda. Plausibility of a third wave of COVID-19 in India. Indian Journal of Medical Research, 05/06-2021. doi:

E Brooks-Pollock, L Danon, T Jombart, L Pellis. Modelling that shaped the early COVID-19 pandemic response in the UK. Philosophical Transactions of the Royal Society, 31-05-2021. doi:

T Jombart, S Ghozzi, D Schumacher et al. Real-time monitoring of COVID-19 dynamics using automated trend fitting and anomaly detection. Philosophical Transactions of the Royal Society, 31-05-2021. doi:

S Riley, KEC Ainslie, O Eales et al. Resurgence of SARS-CoV-2 in England: detection by community antigen surveillance. Science, 28-05-2021. doi:   

FRR Moreira, DM Bonfim, DAG Zauli et al. Epidemic spread of SARS-CoV-2 lineage B.1.1.7 in Brazil. Viruses, 26-05-2021. doi:

NR Faria, T Mellan, C Whittaker et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science, 21-05-2021. doi:

AB Hogan, P Winskill, OJ Watson et al. Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis. Vaccine, 21-05-2021. doi:

FA Lovell-Read, S Funk, U Obolski, CA Donnelly, RN Thompson. Interventions targeting non-symptomatic cases can be important to prevent local outbreaks: SARS-CoV-2 as a case study. Journal of the Royal Society Interface, 19-05-2021. doi:

CBF Vogels, MI Breban, IM Ott et al. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2. PLOS Biology, 07-05-2021. doi:

H Ward, GS Cooke, C Atchison et al. Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: serial cross-sectional studies of 365,000 adults. The Lancet Regional Health – Europe 4, 02-05-2021. doi:

SL Li, RHM Pereira, CA Prete Jr et al. Higher risk of death from COVID-19 in low-income and non-White populations of São Paulo, Brazil. BMJ Global Health, 29-04-2021. doi:

S Riley, KEC Ainslie, O Eales et al. Resurgence of SARS-CoV-2: detection by community viral surveillance. Science 23-04-2021. doi:

OJ Watson, M Alhaffar, Z Mehchy et al. Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria. Nature Communications, 22-04-21. doi:

DJ Laydon, S Mishra, WR Hinsley et al. Modelling the impact of the tier system on SARS-COV-2 transmission in the UK between the first and second national lockdowns. BMJ Open, 22-04-2021. doi:

S Riley, C Atchison, D Ashby et al.  (REACT Study Group). Real-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol. Wellcome Open Research, 21-04-2021. doi:

M Ragonnet-Cronin, O Boyd, L Geidelberg et al. Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions. Nature Communications, 12-04-21. doi:

MS Graham, CH Sudre, A May et al. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. The Lancet Public Health, 12-04-2021. doi:

R McCabe, MD Kont, N Schmit et al. Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries. International Journal of Epidemiology, 09-04-21, doi:

E Volz, S Mishra, M Chand et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature. 25-03-2021.

L. Geidelberg, O Boyd, D Jorgensen et al. Genomic epidemiology of a densely sampled COVID-19 outbreak in China. Virus Evolution, 14-03-2021. doi:

S Ricks, EA Kendall, DW Dowdy et al. Quantifying the potential value of antigen-detection rapid diagnosis tests for COVID-19: a modelling analysis. BMC Medicine, 09-03-2021. doi:

AA de Souza Santos, D da Silva Candido, WM de Souza et al. Dataset on SARS-CoV-2 non-pharmaceutical interventions in Brazilian municipalities. Nature, 04-03-2021. doi:

M Moshe, A Daunt, B Flower et al. SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study. BMJ, 02-03-2021. doi:

WM de Souza, MR Amorim, R Sesti-Costa et al. Levels of SARS-CoV-2 Lineage P.1 Neutralization by Antibodies Elicited after Natural Infection and Vaccination. The Lancet, 01-03-2021. doi:

D Franco, C Gonzalez, LE Abrego et al. Early Transmission Dynamics, Spread, and Genomic Characterization of SARS-CoV-2 in Panama. Emerging Infectious Diseases; 02-2021, doi: 

KM Mitchell, D Dimitrov, R Silhol et al. The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study. The Lancet HIV; 19-02-2021, doi: 

JM Brauner, S Mindermann, M Sharma et al. Inferring the effectiveness of government interventions against COVID-19. Science, 19-02-2021. doi:

P Nouvellet, S Bhatia, A Cori et al. Reduction in mobility and COVID-19 transmission. Nature Communications; 17-02-2021, doi: 

L Du Plessis, JT McCrone, AE Zarebski et al. Establishment and linage dynamics of the SARS-CoV-2 epidemic in the UK. Science, 12-02-2021. doi:

H Ward, C Atchison, M Whitaker et al. SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nature Communications; 10-02-2021, doi: 

HA Thompson, A Mousa, A Dighe et al. SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis. Clinical Infectious Diseases; 09-02-2021, doi: 

SA Kemp, DA Collier, RP Datir et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature, 05-02-2021. doi:

M Monod, A Blenkinsop, X Xi et al. Age groups that sustain resurging COVID-19 epidemics in the United States. Science; 02-02-2021, doi: 

P Christen, JC D'Aeth, A Lochen et al. The J-IDEA Pandemic Planner: A Framework for Implementing Hospital Provision Interventions During the COVID-19 Pandemic. Journal of Medical Care; 21-01-2021, doi: 

JID Hamley, DJ Blok, M Walker et al. What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination? Transactions of the Royal Society of Tropical Medicine and Hygiene; 29-01-2021, doi: 

P Middleton, PN Perez-Guzman, A Cheng et al. Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study. Scientific Reports; 28-01-2021, doi: 

S Mandal, H Das, S Deo, N Arinaminpathy. Combining serology with case-detection, to allow the easing of restrictions against SARS-CoV-2: a modelling-based study in India. Scientific Reports; 29-01-2021, doi: 

K Kura, D Ayabina, J Toor et al. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies. Transactions of the Royal Society of Tropical Medicine and Hygiene; 29-01-2021, doi: 

LF Buss, CA Prete Jr, CMM Abrahim et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science; 15-01-2021, doi: https://doi.org/10.1126/science.abe9728

L du Plessis, JT McCrone, AE Zarebski et al.  Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science; 08-01-2021, doi: 

CJ Atchison, L Bowman, C Vrinten, et al. Perceptions and behavioural responses of the general public during the COVID-19 pandemic: A cross-sectional survey of UK Adults. BMJ Open Research; 04-01-2021, doi:

EM Volz, V Hill, JT McCrone et al. Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity. Cell, 01-09-2020. doi:

G Li, Y Liu, X Jing et al. Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study. Aging; 31-12-2020, doi: 

V Malizia, F Giardina, C Vegvari et al. Modelling the impact of COVID-19-related control programme interruptions on progress towards the WHO 2030 target for soil-transmitted helminths. Transactions of the Royal Society of Tropical Medicine and Hygiene; 14-12-2020, doi: 

LF Buss, CA Prete Jr, CMM Abrahim et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science; 08-12-2020, doi: 

HJT Unwin, S Mishra, VC Bradley et al. State-level tracking of COVID-19 in the United States. Nature Comms; 03-12-2020, doi: 

H Fu, H Wang, X Xi et al. Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China. International Journal of Infectious Diseases; first online 02-12-2020, doi: 

KV Parag, CA Donnelly, R Jha, RN Thompson. An exact method for quantifying the reliability of end-of-epidemic declarations in real time. PLoS Computational Biology; 30-11-2020, doi: 

M Biggerstaff, BJ Cowling, ZM Cucunubá et al. for the WHO COVID-19 Modelling Parameters Group. Early insights from statistical and mathematical modeling of key epidemiologic parameters of COVID-19. Emerg Infect Dis. 26-11-2020, doi: 

I Hawryluk, TA Mellan, H Hoeltgebaum et al. Inference of COVID-19 epidemiological distributions from Brazilian hospital data. Journal of the Royal Society Interface; 25-11-2020, doi: 

RM Anderson, C Vegvari, J Truscott, BJ Collyer. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. The Lancet; 04-11-2020, doi: 

S Dellicour, K Durkin, SL Hong et al. A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages. Molecular Biology and Evolution; 03-11-2020, doi: 

L Cilloni, H Fu, JF Vesga et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine; 01-11-2020, doi: 

MT Maurano, S Ramaswami, P Zappile et al. Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region. Genome Research; 22-10-2020, doi: 

R McCabe, N Schmit, P Christen et al. Adapting hospital capacity to meet changing demands during the COVID-19 pandemic. BMC Medicine; 16-10-2020, doi: 

A Daunt, PN Perez-Guzman, J Cafferkey et al. Factors associated with reattendance to emergency services following COVID‐19 hospitalization. Journal of Medical Virology; 12-10-2020, doi: 

DJ Weiss, A Bertozzi-Villa, SF Rumisha et al. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis. The Lancet Infectious Diseases; 21-09-2020, doi: 

L Wang, H Ma, KCY Yiu et al. Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study. CMAJ Open; 09-10-2020, doi: 

A Dighe, L Cattarino, G Cuomo-Dannenburg et al. Response to COVID-19 in South Korea and implications for lifting stringent interventions. BMC Medicine; 09-10-2020, doi: 

J Toor, ER Adams, M Aliee et al. Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation. Clinical Infectious Diseases; 28-09-2020, doi: 

DS Candido, IM Claro, JG de Jesus et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science ; 04-09-2020, doi: 

HA Thompson, N Imai, A Dighe et al. SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China. Journal of Travel Medicine; 24-08-2020, doi:  

NC Grassly, M Pons-Salort, EPK Parker et al. Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study. Lancet Infectious Diseases; 18-08-2020, doi:  

B Flower, JC Brown, B Simmons et al. Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey. BMJ Thorax; 12-08-2020, doi: 

C Atchison, P Pristera, E Cooper et al. Usability and acceptability of home-based self-testing for SARS-CoV-2 antibodies for population surveillance. Clinical Infectious Diseases, 12-08-2020, doi: 

RN Thompson, TD Hollingsworth, V Isham et al. Key questions for modelling COVID-19 exit strategies. Proceedings of the Royal Society London, 12-08-2020. doi:  

C Poletto, SV Scarpino, EM Volz. Applications of predictive modelling early in the COVID-19 epidemic. The Lancet Digital Health; 10-08-2020, doi: 

PN Perez-Guzman, A Daunt, S Mukherjee et al. Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study.  Clinical Infectious Diseases; 07-08-2020, doi: 

SD Hillis, HJT Unwin, Y Chen et al. Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study. The Lancet, 31-07-2021. doi:  

WM de Souza, LF Buss, D da Silva Candido et al. Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil. Nature Human Behaviour; 31-07-2020, doi: 

X Deng, W Gu, S Federman et al. Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California. Science; 31-07-2020, doi: 

CA Prete, L Buss, A Dighe et al. Serial interval distribution of SARS-CoV-2 infection in Brazil. Journal of Travel Medicine, 25-07-2020, doi:  

DS Candido , IM Claro, JG de Jesus et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science; 23-07-2020, doi: 

D Armstrong-James, J Youngs, T Bicanic et al. Confronting and mitigating the risk of COVID-19 Associated Pulmonary Aspergillosis (CAPA). European Respiratory Journal, 23-07-2020, 

M Skovdal, MR Pickles, TB Hallettt et al. Complexities to consider when communicating risk of COVID-19. Public Health, 23-07-2020. doi: 

G Meyerowitz-Katz, S Bhatt, O Ratmann et al. Is the cure really worse than the disease? The health impacts of lockdowns during COVID-19. BMJ Global Health, 19-07-2021. doi:

B Jeffrey, CE Walters, KEC Ainslie et al. Anonymised and aggregated crowd level mobility data from mobile phones suggests that initial compliance with COVID-19 social distancing interventions was high and geographically consistent across the UK. Wellcome Open Research; 17-07-2020, doi: 

AB Hogan, B Jewell, E Sherrard-Smith et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Global Health; 13-07-2020, doi: 

FG Sandman, PJ White, M Ramsay et al. Optimising benefits of testing key workers for infection with SARS-CoV-2: A mathematical modelling analysis. Clinical Infectious Diseases, 08-07-2020, doi: 

E Lavezzo, E Frachnin, C Ciavarella et al. Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’. Nature; 30-06-2020, doi: 

PT Walker, C Whittaker, OJ Watson et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science; 12-06-2020, doi:   

S. Flaxman, S Mishra, A Gandi et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature; 08-06-2020, published online. 

K Krawczyk, T Chelkowski, DJ Laydon et al. Quantifying Online News Media Coverage of the COVID-19 Pandemic: Text Mining Study and Resource. Journal of Medical Internet Research. doi:

M Jit, T Jombart, ES Nightingale et al. Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020. Eurosurveillance; 07-05-2020, doi: 

KEC Ainslie, CE Walters, H Fu et al. Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment. Wellcome Open Research; 28-04-2020, 5:81, doi: 

T Jombart, K van Zandvoort, TW Russell et al. Inferring the number of COVID-19 cases from recently reported deaths. Wellcome Open Research; 27-04-2020, doi: 

R Verity, LC Okell, I Dorigatti et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infectious Diseases; 30-03-2020, doi: 

D Da S Candido, A Watts, L Abade et al. Routes for COVID-19 importation in Brazil. Journal of Travel Medicine; 23-03-2020, doi: